key: cord-0332118-29u42wzh authors: Kiemes, A.; Serrano Navacerrada, M. E.; Kim, E.; Randall, K.; Simmons, C.; Rojo Gonzalez, L.; Petrinovic, M.M.; Lythgoe, D.J.; Rotaru, D.; Di Censo, D.; Hirshler, L.; Barbier, E. L.; Vernon, A. C.; Stone, J. M.; Davies, C.; Cash, D.; Modinos, G. title: Erbb4 deletion from fast-spiking interneurons causes psychosis-relevant neuroimaging phenotypes date: 2022-03-08 journal: bioRxiv DOI: 10.1101/2022.03.07.483347 sha: 6d06f0097249f485f468213cbc842502782168af doc_id: 332118 cord_uid: 29u42wzh Converging lines of evidence suggest that dysfunction of cortical parvalbumin-expressing (PV+) GABAergic interneurons is a core feature of psychosis. This dysfunction is thought to underlie neuroimaging abnormalities commonly found in patients with psychosis, particularly in the hippocampus. These include increases in resting cerebral blood flow (CBF) and levels of glutamatergic metabolites, and decreases in binding of GABAA α5 receptors and the synaptic density marker synaptic vesicle glycoprotein 2A (SV2A). However, direct links between PV+ interneuron dysfunction and these neuroimaging readouts have yet to be established. Conditional deletion of a schizophrenia susceptibility gene, the tyrosine kinase receptor Erbb4, from cortical and hippocampal PV+ interneurons leads to several synaptic, behavioral and cognitive phenotypes relevant to psychosis in mice. Here, we investigated how this PV+ interneuron disruption affects the hippocampal in vivo neuroimaging readouts in the Erbb4 model. Adult Erbb4 conditional mutant mice (Lhx6-Cre;Erbb4F/F, n=12) and their wild-type littermates (Erbb4F/F, n=12) were scanned in a 9.4T magnetic resonance scanner to quantify CBF and glutamatergic metabolite levels (glutamine, glutamate, GABA). Subsequently, we assessed GABAA receptors and SV2A density using quantitative autoradiography. Erbb4 mutant mice showed significantly elevated CBF and glutamine levels, as well as decreased SV2A density compared to wild-type littermates. No significant GABAA receptor density differences were identified. These findings demonstrate that specific disruption of cortical PV+ interneurons in mice recapitulate some of the key neuroimaging findings in psychosis patients, and link PV+ interneuron deficits to non-invasive, translational measures of brain function and neurochemistry that can be used across species. Multiple lines of evidence suggest that inhibitory GABAergic interneuron dysfunction is a core feature of psychosis 1 , and that this dysfunction underlies the abnormalities in hippocampal activity commonly observed in the disorder 2 . More specifically, post-mortem human brain studies in psychosis have identified reductions in the GABA-synthesizing enzyme GAD67 3 , inhibitory interneuron number 4 , calcium-binding protein parvalbumin (PV) expressed by some GABAergic interneurons 5, 6 , and increases in GABAA receptor density 7 . Among these, PV+ interneurons, a type of fast-spiking GABAergic cells that modulate neural network oscillations at the gamma frequency 8 , have been implicated in the pathophysiology of psychosis [9] [10] [11] . Abnormal gamma oscillations have been identified in individuals with psychosis spectrum disorders 12, 13 and are thought to underlie their cognitive symptoms 14 . Experiments in a neurodevelopmental animal model (methylazoxymethanol model, MAM) demonstrated that PV+ interneuron loss in the hippocampus leads to psychosis-relevant neurophysiological and cognitive deficits (i.e. reduced oscillatory activity and impaired latent inhibition) 11 . These findings led to the hypothesis that PV+ interneuron dysfunction in the hippocampus plays a critical role in the pathophysiology of psychosis 15, 16 . Briefly, PV+ disruption in the hippocampus disinhibits glutamatergic excitatory cell activity, resulting in local hyperactivity. This drives an increase in striatal dopamine through descending projections, proposed to underlie psychosis symptoms. A hyperactive and dysrhythmic hippocampus can also interfere with the function of hippocampal-prefrontal cortex projections, disrupting prefrontal activity and rhythmicity, leading to cognitive deficits 15,16 . In humans, neuroimaging studies have identified hippocampal abnormalities consistent with a fundamental role of GABAergic dysfunction in the pathophysiology of psychosis. Patients with psychosis exhibit hippocampal hyperactivity as indexed by increased regional cerebral blood flow (CBF) 17, 18 and cerebral blood volume (CBV) [19] [20] [21] [22] [23] . Such hyperactivity has been linked to higher severity of positive symptoms such as delusions and hallucinations 2, 15, 24 . Increases in CBF are also observed in psychosis vulnerability states, including individuals at clinical high-risk (CHR) for psychosis and healthy individuals with high schizotypy [25] [26] [27] [28] . As mentioned above, such activity increases are proposed to result from GABAergic interneuron dysfunction 2 . Supporting this premise, a positron emission tomography (PET) study with the non-selective GABAA receptor (α1-3;5GABAAR) tracer [ 11 C]flumazenil found increases in in vivo GABAA receptor binding in antipsychotic-naïve psychosis patients, that were linked to their cognitive symptoms and abnormal cortical oscillations 29 . More recently, studies using the more selective PET radiotracer [ 11 C]Ro15-4513, reported binding decreases in hippocampal GABAA α5 receptors (α5GABAAR) in antipsychotic-free patients 30 This corroborates post-mortem 34-39 findings of decreased dendritic spines and synaptic markers, as well as genetic evidence of variants in synaptic protein coding genes [40] [41] [42] [43] . Finally, other studies using proton magnetic resonance spectroscopy ( 1 H-MRS) to quantify excitatory and inhibitory metabolites in the hippocampus identified increases in the levels of combined glutamine and glutamate (Glx) 44,45 , but not GABA 46, 47 , in patients with psychosis compared to healthy controls. Despite these recent human neuroimaging advances supporting a key mechanistic role for GABAergic dysfunction in psychosis, such neuroimaging assessments cannot inform whether these signal changes are associated with specific neuronal subpopulations, such as PV+ interneurons. One way to address this issue is by targeted (e.g. genetic) modification of specific cell types in animal models. This allows the effects of such genetic modifications to be assessed using the same neuroimaging modalities used in human (clinical) studies 48, 49 , providing more direct evidence linking cellular defects to macroscopic in vivo neuroimaging changes. For example, previous work in the cyclin D2 knockout model identified increased CBV as a result of hippocampal PV+ interneuron reduction 50 . In another mouse model, deletion of the tyrosine kinase receptor Erbb4 (a susceptibility gene linked to psychosis 51, 52 ) from PV+ interneurons 53, 54 in the cortex and hippocampus leads to several psychosisrelevant phenotypes [55] [56] [57] [58] . These include synaptic deficits (e.g., decreased interneuron signaling in the hippocampus, dysregulated glutamatergic activity of hippocampal pyramidal cells) 55 , elevated striatal dopamine 58 and psychosis-relevant behaviors (e.g., hyperlocomotion, impaired prepulse inhibition, impaired cognitive and social behavior) 55 . Erbb4 mutant mice thus represent a suitable model in which to analyze the contribution of PV+ interneuron dysfunction to hippocampal abnormalities associated with psychosis using non-invasive, clinically translational neuroimaging methods. Our study used the Erbb4 mouse model to determine how the PV+ interneuron dysfunction affects in vivo functional neuroimaging readouts commonly used in humans: arterial spin labeling (ASL) to measure CBF, and 1 H-MRS to measure glutamate, glutamine and GABA levels in the hippocampus. Next, we sought to characterize hippocampal receptor and synaptic densities in this model, using ex vivo quantitative autoradiography with radioligands previously used in human in vivo PET studies: Based on the synaptic deficits previously reported in these animals 55 , and the evidence that PV+ interneuron deficits underlie hippocampal hyperactivity in psychosis 2 , we hypothesized that Erbb4 mouse mutants would show increases in CBF, glutamatergic metabolites and α1-3;5GABAAR density, as well as decreases in α5GABAAR and SV2A density in the hippocampus compared to wild-type littermate controls. All animal procedures were performed in accordance with UK Home Office Animals (Scientific Procedures) Act 1986 and approved by the local King's College London Animal Welfare Ethical Review Body. Animals were maintained under standard laboratory conditions on a 12:12 light/dark cycle with water and food ad libitum. Mice carrying loxP-flanked Erbb4 alleles 56 were crossed with Lhx6-Cre mice 59 to generate Lhx6-Cre;Erbb4 F/F conditional mutants. Wild-type Erbb4 F/F littermates were used as controls. Twelve Lhx6-Cre;ErbB4 F/F (9 female; 3 male) and 12 Erbb4 F/F control (5 female; 7 male) adult (PD98 ± 11 days) mice underwent in vivo MR imaging. MR images were acquired using a 9.4T Bruker BioSpec 94/20 scanner with an 86-mm volume transmission coil and receive-only 2x2 surface array coil. All MR data were acquired from anesthetized animals (see Anesthesia section below) in a single scanning session and the brains were collected immediately after scanning for quantitative autoradiography. Mice were initially anesthetized with 5% isoflurane in a mixture of 70% air and 30% oxygen. Once they were positioned on the scanner bed, a subcutaneous bolus of medetomidine (0.05 mg/kg) was administered and the isoflurane reduced to 1.5%. Eight minutes after the bolus, a subcutaneous infusion of medetomidine (0.1 mg/kg/hr) was started and maintained until the end of the ASL scan 60, 61 . Then, the medetomidine infusion was stopped and the isoflurane level was increased to 2% for the remaining scans. Pseudo-continuous ASL (pCASL) was used to quantify CBF. The pCASL protocol includes a perfusion scan and two pre-scans to determine the optimal label and control phase increments and an inversion efficiency (IE) scan for each mouse 62 . The labeling slice was positioned 5 mm upstream of the carotid bifurcation identified by localizer scans of the neck. The labeling duration ( ) and post-label delay were 3000/300 ms, 1500/300 ms, and 200/0 ms for the perfusion scan, pre-scans, and IE scan, respectively. Custom MATLAB scripts were written to calculate the mean IE in manually drawn regions of interest (ROIs) around both carotid arteries and quantitative CBF maps using the following equations: Mcontrol and Mlabel are the complex signals from the control and label images from the IE scan, SIcontrol and SIlabel are the time-averaged signal intensities of the control and label images from the perfusion scan, assuming the blood-brain partition coefficient = 0.9 ml/g, and T1blood = 2.4 s. The T1 images were used to register all subjects to the Allen mouse brain Common Coordinate Framework v3 (CCFv3) using antsRegistration to perform sequential rigid-body, affine, and SyN diffeomorphic registrations (ANTs v2.1.0 65 ). CBF maps were normalized by the mean CBF of the whole brain, and then mean CBF values were calculated for 21 ROIs derived from the CCFv3 atlas labels. We focused our analyses on the dorsal and ventral hippocampus (Figure 2A ). For completeness, exploratory independent t-tests of other atlas-derived ROIs are presented in the supplementary materials (Table S2) . 20% are classified as not accurately detectable and are discarded 72, 73 . Using these criteria no data had to be discarded for our metabolites of interest: gamma-aminobutyric acid (GABA), glutamine (Gln), and glutamate (Glu) (Figure 1 ). Following the MR scanning, mice were sacrificed, the brains dissected, and flash frozen in cold (-40°C) isopentane on dry ice, then stored at -80°C. Frozen brains were coronally cryosectioned at 20µm and mounted onto glass slides, then dried on a hotplate. Quantitative autoradiography was performed as previously described 74 Figure 1A ). Owing to better signal/contrast to noise ratio of [ 3 H]UCB-J autoradiographs ( Figure 1B) , we were also able to analyze the binding in the dentate gyrus. These hippocampal ROIs were selected based on previous evidence implicating their involvement in psychosis 19 To better graphically depict the comparison between different 1 H-MRS metabolites ( Figure 3B ), we calculated z scores of individual concentrations in relation to the pooled group mean metabolite concentration. Figure 3B and Table 1 ). There were no significant group differences in either glutamate or GABA concentrations (Table 1) . Figure 4C ). gyrus. In this study, we used conditional Erbb4 mutants to examine the effects of PV+ inhibitory interneuron dysfunction on key neuroimaging markers of psychosis. We identified abnormalities in hippocampal activity, neurochemistry and synaptic density that are largely convergent with clinical neuroimaging findings in patients. More specifically, compared to wild-type mice, Erbb4 mutants showed increased CBF and glutamine levels in the ventral hippocampus, as well as decreases in SV2A levels across hippocampal sub-regions. GABA and glutamate levels did not significantly differ between the groups, and there were no differences in the density of any of the measured GABAergic receptors. Tables S1, S3-5 and Supplementary Discussion) we found additional group differences, although these did not survive multiple comparisons correction. Thus, in Erbb4 mutant mice, we observed further elevations of CBF in the entorhinal cortex and increases of α5GABAAR density in the retrosplenial cortex. Additionally, decreases in α1-3;5GABAAR density in the retrosplenial cortex approached significance. Our investigation focused primarily on the hippocampus, based on pre-existing hypotheses suggesting that PV+ interneuron loss in the ventral part of this region contributes to its hyperactivity and is associated with further electrophysiological and cognitive deficits relevant to psychosis 2,15 . Indeed, hippocampal disinhibition is suggested to disrupt cognitive functioning in schizophrenia 15 , consistent with the vital role of PV+ interneurons in entraining gamma oscillations 8 . In concordance with the hippocampal hyperactivity hypothesis 2 , in the Erbb4 model of PV+ interneuron dysfunction, inhibitory control over pyramidal neurons is disrupted 55 , leading to increased neural activity captured by CBF via neurovascular coupling 85 . Importantly, our findings are localized to the ventral part of the hippocampus, matching the previous findings of increased CBV in psychosis patients 19, [21] [22] [23] and CBF in CHR patients 26, 28 in the human anatomical equivalent, the anterior hippocampus. Further, our findings align with previous evidence of increased CBV in the cyclin D2 knockout model that exhibits PV+ interneuron loss 50 . Here, we used a model that manipulates an established schizophrenia susceptibility gene instead, and expand findings of PV+ interneuron related hippocampal hyperactivity in the less invasive and quantitative MR method of ASL. In terms of our 1 H-MRS findings, we identified an increase in glutamine, but not glutamate or GABA, in the ventral hippocampal region. Disinhibition of pyramidal neuronal activity in the Erbb4 model 53, 55, 86 , is thought to lead to increased glutamate release 87, 88 . However, glutamine, a precursor of glutamate, could be considered a better indicator of glutamatergic neurotransmission 89 . This is based on the premise that any synaptically released glutamate is quickly taken up by astrocytes and recycled to glutamine 90, 91 . Accordingly, increased glutamine in the medial temporal lobe / hippocampi has previously been detected by 1 H-MRS in psychosis patients 44 . Other human studies also showed evidence of elevated Glx 44,45 -a composite of glutamate and glutamine -that is preferentially measured at lower magnetic fields such as 1.5 or 3T in humans, where the separation between those two metabolites is not robust 92 . These findings suggest that increased glutamine may be a good indicator of elevated glutamatergic neurotransmission and it occurs as a consequence of PV+ interneuron dysfunction. Furthermore, no Erbb4 genotype effect was observed in hippocampal 1 H-MRS GABA levels. Previous findings in conditional Erbb4 mutants had identified reduced expression of two GABA synthesizing GAD isomers, GAD65 and GAD67, as well as reduced frequency of miniature inhibitory postsynaptic GABAergic currents 55 . However, it is also known that, as a result of PV+ inhibitory neuron disruption, both PV+ interneurons and excitatory pyramidal cells eventually become hyperactive in Erbb4 mutants through possible compensatory mechanism in order to maintain excitation/inhibition balance 55 . This compensatory inhibitory interneuron activity may counteract any deficits in GABA synthesis, thereby explaining the lack of measurable differences in GABA between the groups. Indeed, no changes in hippocampal GABA levels were identified in psychosis patients by a previous 1 H-MRS GABA study 46 . Although we hypothesized changes in hippocampal GABAergic receptor densities as a result of PV+ interneuron disruption, we found no differences between Erbb4 mutants and control mice in either α1-3;5GABAAR or α5GABAAR. In humans, increases in α1-3;5GABAAR availability 29 and decreases in the more specific α5GABAAR 30 have been identified in groups of antipsychotic-naïve and medication-free schizophrenia patients, respectively. As Erbb4 deletion specifically affects PV+ interneurons, a lack of α5GABAAR changes may be due to this subunit's putative co-expression with somatostatin-expressing rather than PV+ interneurons 78 In summary, our study provides direct evidence linking PV+ interneuron dysfunction in the Erbb4 mouse model to analogues of in vivo neuroimaging alterations previously identified in psychosis and CHR patients. These alterations include increased CBF and glutamine levels, as well as reduced synaptic density in the hippocampus. Overall, these findings suggest that the use of translational neuroimaging methods may be a viable strategy to identify new therapeutic targets and serve as noninvasive measures of target engagement. Furthermore, our findings support the view that targeting inhibitory dysfunction in the hippocampus may be a promising therapeutic strategy for psychosis. Interneuron dysfunction in psychiatric disorders GABAergic mechanisms of hippocampal hyperactivity in schizophrenia Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Archives of general psychiatry A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives A selective decrease in the relative density of parvalbuminimmunoreactive neurons in the hippocampus in schizophrenia Hippocampal interneurons are abnormal in schizophrenia Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain Parvalbumin and Somatostatin Interneurons Contribute to the Generation of Hippocampal Gamma Oscillations Cortical basket cell dysfunction in schizophrenia The chandelier neuron in schizophrenia A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia Gamma oscillations in schizophrenia: Mechanisms and clinical significance Gamma band oscillations in the early phase of psychosis: A systematic review Abnormal neural oscillations and synchrony in schizophrenia The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression Patterns of Cerebral Blood Flow in Schizophrenia Probing the human hippocampus using rCBF: Contrasts in schizophrenia Increased hippocampal CA1 cerebral blood volume in schizophrenia Increased hippocampal blood volume and normal blood flow in schizophrenia Hyperactivity and Reduced Activation of Anterior Hippocampus in Early Psychosis Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia Dopamine System Dysregulation by the Ventral Subiculum as the Common Pathophysiological Basis for Schizophrenia Psychosis, Psychostimulant Abuse, and Stress Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort Increased resting perfusion of the hippocampus in high positive schizotypy: A pseudocontinuous arterial spin labeling study Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513. Molecular Psychiatry GABAA/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for α5 subunit Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats In vivo evidence of lower synaptic vesicle density in schizophrenia Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains Molecular evidence of synaptic pathology in the CA1 region in schizophrenia Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex Schizophrenia risk from complex variation of complement component 4 De novo mutations in schizophrenia implicate synaptic networks A polygenic burden of rare disruptive mutations in schizophrenia Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies. Molecular Psychiatry Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis The critical importance of basic animal research for neuropsychiatric disorders Small animal imaging presents an opportunity for improving translational research in biological psychiatry Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition The involvement of ErbB4 with schizophrenia: Association and expression studies Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse GABAergic Abnormalities Associated with Sensorimotor Corticostriatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naive Patients with Schizophrenia ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors Spatial genetic patterning of the embryonic neuroepithelium generates GABAergic interneuron diversity in the adult cortex Optimization of anesthesia protocol for restingstate fMRI in mice based on differential effects of anesthetics on functional connectivity patterns Common functional networks in the mouse brain revealed by multi-centre resting-state fMRI analysis Interpulse phase corrections for unbalanced pseudo-continuous arterial spin labeling at high magnetic field How to correct susceptibility distortions in spin-echo echoplanar images: application to diffusion tensor imaging QUIT: QUantitative Imaging Tools Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain Longitudinal in vivo maturational changes of metabolites in the prefrontal cortex of rats exposed to polyinosinic-polycytidylic acid in utero Metabolite detection by proton magnetic resonance spectroscopy using PRESS Advanced processing and simulation of MRS data using the FID appliance (FID-A)-An open source, MATLAB-based toolkit Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine Automatic quantitation of localized in vivo 1H spectra with LCModel Vivo 1H Magnetic Resonance Spectroscopy A longitudinal study of cognition, proton MR spectroscopy and synaptic and neuronal pathology in aging wild-type and AβPPswe-PS1dE9 mice In vivo proton magnetic resonance spectroscopy (1H-MRS) evaluation of the metabolite concentration of optic radiation in primary open angle glaucoma Region-specific and dose-specific effects of chronic haloperidol exposure on [3H]-flumazenil and [3H]-Ro15-4513 GABAA receptor binding sites in the rat brain GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia Quantification of [11C]Ro15-4513 GABAAα5 specific binding and regional selectivity in humans Characterisation of the Contribution of the GABA-Benzodiazepine α1 Receptor Subtype to [11C]Ro15-4513 PET Images Cellular and molecular signatures of in vivo GABAergic neurotransmission in the human brain Structure, pharmacology, and function of GABAA receptor subtypes Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model effectsize: Estimation of Effect Size Indices and Standardized Parameters Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates Coupling of function, metabolism, and blood flow in the brain Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics In vivo NMR Studies of the Glutamate Neurotransmitter Flux and Neuroenergetics: Implications for Brain Function Field strength dependence of PRESS timings for simultaneous detection of glutamate and glutamine from 1.5 to 7T Morphology and Distribution of Chandelier Cell Axon Terminals in the Mouse Cerebral Cortex and Claustroamygdaloid Complex Sex differences in animal models of schizophrenia shed light on the underlying pathophysiology Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects Sex as a Biological Variable: A 5-Year Progress Report and Call to Action Sex bias in preclinical research and an exploration of how to change the status quo Animal models of schizophrenia The authors would kindly like to thank Bernard Clemence and Beatriz Rico for kindly providing the animals in this study. We would also like to thank Beatriz Rico for generously contributing her expertise and input to the interpretation of findings.